| 摘要 |
<p>ABSTRACT The present invention relates to a process for preparing impurity of Esomeprazole or its pharmaceutically acceptable salt, for example, N-methyl esomeprazole of Formula IIa and IIb, which is useful as reference marker or a key intermediate to quantify its presence in Esomeprazole. Formula IIa Formula IIb</p> |
